Clinical Trial Update: A Randomized Study of JS004 and Toripalimab Combined With Chemotherapy vs Toripalimab Combined With Chemotherapy vs Chemotherapy Alone as Neoadjuvant Therapy for Stage II-III Triple-negative Breast Cancer (TNBC). [Phase 2]

View source ↗

Summary

Phase 2 randomized neoadjuvant trial evaluating JS004 plus toripalimab with chemotherapy versus toripalimab with chemotherapy and chemotherapy alone for Stage I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• JS004 (JS004)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Shengjing Hospital | Conditions: TNBC - Triple-Negative Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING